Simply Wall St.
A Look At Soleno Therapeutics (SLNO) Valuation As Oppenheimer Updates Vykat XR Launch And 2026 Sales Outlook
๐
AI Sentiment
Positive
6/10
Latest updates and market news for OPY
AI Sentiment
Positive
6/10
AI Sentiment
Positive
7/10
AI Sentiment
Highly Positive
8/10
AI Sentiment
Highly Positive
8/10
Share this news page